Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kaisa Health Group HoldingsHKSE:00876 +37.92%40 Days Inventory is 64.43 as of Dec. 2025, which is 72% above its 10-year median of 37.56. GuruFocus rates HKSE:00876 with a GF Score™ of 40/100 and a GF Value™ of HK$0.95 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Kaisa Health Group Holdings ranks better than 92.13% on this metric.
The historical rank and industry rank for Kaisa Health Group Holdings's Days Inventory or its related term are showing as below:
HKSE:00876'
s Days Inventory Range Over the Past 10 Years
Min: 9.15 Med: 37.56 Max: 509.67
Current: 61.21
During the past 13 years, Kaisa Health Group Holdings's highest Days Inventory was 509.67. The lowest was 9.15. And the median was 37.56.
HKSE:00876's Days Inventory is ranked better than 92.13% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 177.64
vs HKSE:00876: 61.21
Inventory Turnover measures how fast the company turns over its inventory within a year.
Kaisa Health Group Holdings's Inventory Turnover for the
six
months ended in Dec. 2025 was 2.83.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Kaisa Health Group Holdings's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.22.
Kaisa Health Group Holdings (HKSE:00876) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Kaisa Health Group Holdings's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Kaisa Health Group Holdings's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Kaisa Health Group Holdings Days Inventory Related Terms
Kaisa Health Group Holdings Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:00876 vs ISRG, BDX, MDLN: Days Inventory Comparison
For the Medical Instruments & Supplies subindustry, Kaisa Health Group Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kaisa Health Group Holdings Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Kaisa Health Group Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where Kaisa Health Group Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kaisa Health Group Holdings (HKSE:00876) has a Days Inventory of 64.43 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Kaisa Health Group Holdings and its competitors. This is 72% above median its historical median of 37.56. Over the past decade, Kaisa Health Group Holdings' Days Inventory has ranged from 9.15 to 509.67. According to the industry distribution chart, Kaisa Health Group Holdings ranks #62 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 7.9%.
Is Kaisa Health Group Holdings' Days Inventory too high?
Kaisa Health Group Holdings' current Days Inventory of 64.43 is 72% above median its 10-year median of 37.56. Over the past 10 years, this metric has ranged from a low of 9.15 to a high of 509.67. The Medical Devices & Instruments industry median Days Inventory is 177.64. Kaisa Health Group Holdings' value of 64.43 is 63.7% below this industry median. Based on the distribution chart, Kaisa Health Group Holdings ranks #62 out of 788 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Kaisa Health Group Holdings has a GF Score™ of 40/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kaisa Health Group Holdings' Days Inventory compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Kaisa Health Group Holdings ranks #62 out of 788 companies for Days Inventory. This places Kaisa Health Group Holdings in the top 8% of its industry — outperforming the majority of peers. The industry median Days Inventory is 177.64. Kaisa Health Group Holdings' value of 64.43 is 63.7% below this benchmark. Historically, Kaisa Health Group Holdings' own Days Inventory has ranged from 9.15 to 509.67 over the past decade. While the company's 10-year median is 37.56 vs. the industry median of 177.64, Kaisa Health Group Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 177.64, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kaisa Health Group Holdings's current Days Inventory of 64.43 is 63.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Kaisa Health Group Holdings and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 177.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kaisa Health Group Holdings's current Days Inventory is 64.43, which is 72% above median its own 10-year median of 37.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kaisa Health Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, Kaisa Health Group Holdings (HKSE:00876) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.95, compared to a current price of HK$2.86 — trading 200.5% above its estimated fair value. The current Days Inventory is 64.43, which is 72% above median its 10-year median of 37.56 and 63.7% below the Medical Devices & Instruments industry median of 177.64. Kaisa Health Group Holdings' overall GF Score™ is 40/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Kaisa Health Group Holdings (HKSE:00876), the current Days Inventory is 64.43 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kaisa Health Group Holdings (HKSE:00876) Overvalued in 2026?
Based on GuruFocus' analysis, Kaisa Health Group Holdings stock appears to be overvalued.
The current stock price of HK$2.86 is trading 200.5% above its estimated GF Value™ of HK$0.95.
GuruFocus considers Kaisa Health Group Holdings to be Significantly Overvalued.
Key valuation signals for HKSE:00876:
Days Inventory: 64.43 (72% above median its 10-year median of 37.56)
GF Value™: HK$0.95 vs. price of HK$2.86 (200.5% above fair value)
Industry Position: 63.7% below the Medical Devices & Instruments median (#62 of 788)
No single metric tells the full story. See the HKSE:00876 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kaisa Health Group Holdings Ltd, through its subsidiaries are mainly engaged in the manufacturing and sale of dental prosthetics and implant instruments, and the provision of sports rehabilitation services. The Group operates in two reportable segments: Dental Business, which consists of manufacturing and trading in dental products; and the Health Care Business, which provides services for sport rehabilitation, including postoperative rehabilitation, sports injury rehabilitation, chronic pain, scoliosis, deformity correction, other rehabilitation services, and health leisure business. The majority of its revenue is generated from the Dental business segment. Geographically, the Group generates maximum revenue from the People's Republic of China, and the rest from other countries.
40GF Score
Get the complete analysis for HKSE:00876
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00876 has been successfully added to your 
